1. Munoz FM, Keitel WA. Progress in the diagnosis, prevention, and treatment of pertussis. Curr Inf Dis Rep. 2003;5(3):213–9.
2. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Inf Dis. 2011;11(7):557–70.
3. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55((RR-17):1–37.
4. Cherry JD. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785–7.
5. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Inf Dis J. 2005;24(5 Suppl):S44–47.